RecruitingNot ApplicableNCT05241405

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer - Randomized, Placebo-controlled, Double-blind Study


Sponsor

Centre Francois Baclesse

Enrollment

354 participants

Start Date

Sep 27, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This is a multicenter randomized trial in breast cancer patients reporting cancer-related fatigue to evaluate the efficacy and safety of Qiseng® based on extract of American ginseng combined with vitamin C from extract of Camu Camu berries


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether taking American ginseng supplements for 8 weeks can reduce cancer-related fatigue in patients who have recently finished treatment for early-stage breast or gynecological cancer (such as ovarian or uterine cancer). **You may be eligible if...** - You were treated for localized (non-metastatic) breast or gynecological cancer - Your chemotherapy and/or radiation therapy finished within the past 6 months - You are experiencing persistent fatigue (rated 4 or higher out of 10) for at least one month - You are 18 or older and using effective contraception if of childbearing age **You may NOT be eligible if...** - You are currently receiving active chemotherapy (some maintenance therapies are allowed) - Your cancer has spread (metastatic) - You have anemia or another identified medical cause of fatigue - You have consumed ginseng products in the past month - You are pregnant or breastfeeding - You have diabetes requiring oral medication Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTQISENG

2 capsules/day for 8 weeks.

DIETARY_SUPPLEMENTPLACEBO

2 capsules/day for 8 weeks.


Locations(10)

ARCOCEA_Clinique Europe

Amiens, France

Ch Bayeux

Bayeux, France

Centre Pierre Curie

Beuvry, France

Centre François Baclesse

Caen, France

Polyclinique du Parc

Caen, France

Ch Calais

Calais, France

Ch Cherbourg

Cherbourg, France

Clinique de Flandre

Coudekerque-Branche, France

Centre Henri Becquerel

Rouen, France

Clinique des Dentellières

Valenciennes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05241405


Related Trials